Dr. Chern-Hooi Lim participated and presented in the ICP 2019 conference. Topics presented are: Strongly Reducing Organic Photoredox Catalysts for Visible Light-driven Synthesis of Polymers and Small Molecules Visible-light-driven Conversion of CO2 to CH4 with an Organic Sensitizer and an Iron Porphyrin Catalyst Learn More
New Iridium attended the 2019 ARPA-E Summit. This summit brings together energy stakeholders, industry professionals and technology experts from around the world to discuss and address America’s energy challenges in new and innovative ways. This year’s event recognizes 10 years of ARPA-E making ideas into reality and sets the stage for the next decade of…
New Iridium have executed an Exclusive Licensing Agreement with CU Boulder for the the patent in regards to Compositions and Methods of Promoting Organic Photocatalysis.
Dr. Chern-Hooi Lim attended and presented at the ACS conference. Topics presented are: Strongly reducing organic dihydrophenazine and phenixazine photoredox catalysts for visible light-driven synthesis of polymers and small molecules Benzimidazoles as Metal-Free and Recyclable Hydrides for CO2 Reduction to Formate C-N Cross-Coupling via Photoexcitation of Nickel-Amine Complexes
New Iridium received Phase 1 funding from National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program. NIH SBIR program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development that has the potential for commercialization. Learn More
Dr. Chern-Hooi Lim attended the 14th Winter Conference on Medicinal & Bioorganic Chemistry (WCMBC) conference. Learn More